<DOC>
	<DOCNO>NCT01025167</DOCNO>
	<brief_summary>The purpose study determine impact specific nutrition formula high content eicosapentaenoic acid ( EPA ) fat oncology patient receive radio-/chemotherapy body weight , body composition , nutritional status physical function compare standard nutrition formula . Using adaptive design approximately 80 patient randomize first part study . Following interim analysis 160 patient may add , total 240 patient .</brief_summary>
	<brief_title>The Effect New Specific Enteral Formula Compared Standard Formula Tolerability Combined Radio- Chemotherapy Cancer Patients</brief_title>
	<detailed_description />
	<criteria>patient head &amp; neck cancer oesophagus cancer , enteral nutrition PEG least 14 week , cancer patient receive combine radio/chemotherapy , start nutritional therapy late begin radio/chemotherapy , body mass index &gt; =16 &lt; =30 kg/m2,0 Kondrup Score &gt; =3 SGA = B/C , life expectancy &gt; 6 month , write informed consent . second active carcinoma , severe diarrhea unresponsive codeine/loperamide , positive antiHIVtest ( safety reason ) , pregnant lactate woman , insulindependent diabetes mellitus type I II , patient cardiac pacemaker , allergy content investigational product , milk protein fish oil , patient PEG , participation concurrent clinical study investigational nutritional therapy within one month prior start study , intake muscle growth supportan substance ( e.g . anabolics ) , additional fish oil EPA substitution within last 4 week , SGA status A ( well nourish ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>cancer</keyword>
	<keyword>enteral nutrition</keyword>
	<keyword>omega-3-fatty acid</keyword>
</DOC>